125 results on '"Choudhury, Sirazum"'
Search Results
2. Current Challenges and Future Directions in the Assessment of Glucocorticoid Status
3. Weaning patients off long-term low dose prednisolone: an international survey of current endocrine practice
4. Redefining diagnostic cut-offs for the indirect water deprivation test
5. The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis
6. Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
7. Optimising prednisolone or prednisone replacement in adrenal insufficiency
8. Prednisone is 100% converted to Prednisolone by first pass metabolism
9. Optimising the Insulin Tolerance Test: Cortisol Thresholds on Abbott Platforms should be lowered to 416 nmol/L
10. Prednisolone replacement therapy in Adrenal Insufficiency: Defining target ranges and timing for optimum Prednisolone level sampling
11. 5mg of Prednisolone results in over-replacement in individuals with Adrenal Insufficiency
12. Letter to the editor of clinical endocrinology: Assessment of adrenal function in patients who survive COVID‐19
13. Objective markers and new indicators in adrenal insufficiency- findings from the omni-aid study comparing hydrocortisone and prednisolone replacement therapy
14. Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men
15. The scandal of generic drug pricing: drug regulation policies need review
16. Glucocorticoid replacement in Addison disease
17. Pituitary and gonadal axes in patients with ’Long COVID’: post hoc analysis
18. Improving outcomes from SSTS: Redefining Cortisol Cut-Offs
19. Prednisolone versus Hydrocortisone in Adrenal Insufficiency: A positive and negative control cross-sectional study
20. Improving the interpretation of afternoon cortisol levels and SSTs to prevent misdiagnosis of Adrenal Insufficiency
21. Glycaemic variability assessed by continuous glucose monitoring after Roux-en-Y gastric bypass vs. sleeve gastrectomy
22. Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
23. Letter to the editor of clinical endocrinology: Assessment of adrenal function in patients who survive COVID‐19.
24. The use of whole blood capillary samples to measure 15 analytes for a home-collect biochemistry service during the SARS-CoV-2 pandemic: A proposed model from North West London Pathology
25. The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
26. Roux-en-Y gastric bypass increases glycaemic variability and time in hypoglycaemia in patients with obesity and pre-diabetes/type 2 diabetes mellitus: a prospective cohort study
27. Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study
28. Get ahead! The Situational Judgement Test
29. ONCOLOGICAL OUTCOMES OF ROBOT-ASSISTED RADICAL CYSTECTOMY
30. One hand is better than two: conversion from pure laparoscopic to the hand-assisted approach during difficult nephrectomy
31. The differential effects of weight loss by RYGB versus very-low calorie diet (VLCD) on gut hormone levels and appetite: potential contribution to sustained weight loss
32. Roux-en-Y Gastric Bypass Increases Glycemic Variability and Time in Hypoglycemia in Patients With Obesity and Prediabetes or Type 2 Diabetes: A Prospective Cohort Study.
33. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study
34. Improving glucocorticoid replacement profiles in adrenal insufficiency
35. Inadvertent treatment of hypoadrenalism with prednisolone in pemphigus: A case report
36. Prednisolone in adrenal insufficiency disease
37. Metabolic changes post Roux-En-Y Gastric Bypass: one year prospective study
38. Feasibility of immunological markers and osteocalcin as a barometer of glucocorticoid replacement
39. Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency
40. Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
41. Enteric coating delays the absorption of prednisolone variably and should not be used
42. Does higher cortisol exposure during hydrocortisone replacement therapy lead to osteoporosis?
43. Does cortisol exposure from the Hydrocortisone day curve predict mortality, type II Diabetes or lipid profiles?
44. Lodotra (delayed release prednisone) is variably absorbed, and should not be used in adrenal insufficiency
45. Prednisolone should be first line replacement therapy for adrenal insufficiency
46. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study
47. Prednisolone 3 mg once daily should be the glucocorticoid replacement for hypopituitarism
48. Osteoporosis and low-dose prednisolone: Is there a link? Insights from bone turnover markers
49. Osteocalcin suppression may be a useful marker of steroid exposure
50. Could modified release prednisone hold the key to closer reproduction of the glucocorticoid circadian rhythm in Adrenal Insufficiency?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.